The Online Kenyan Logo

The Online Kenyan

HomeTop StoriesLive TVVideosPoliticsBusinessSportsTechEntertainment
HomeTop StoriesLive TVVideos
PoliticsBusinessSportsTechEntertainment

Footer

The Online Kenyan Logo

The Online Kenyan

News & Breaking Headlines

news@theonlinekenyan.com
+254 758 277 017

Follow Us

Explore

DailiesWeekliesTopicsVideosHow to file 2024 KRA Returns

Legal

  • Privacy Policy
  • Terms of Use
  • AI Content Policy

© 2026 The OK Company. All rights reserved.

Made within Kenya
HomeDaily NewsTuesday, July 8, 2025Health Concerns in Kenya: Vaccines and Malaria Drug Approvals
Breaking News & Top Stories2 stories from 2 sources

Health Concerns in Kenya: Vaccines and Malaria Drug Approvals

Risks to child deaths if vaccine funding falters. A new cherry-flavored malaria drug for babies receives approval.

Listen to this coverage1 min

Read aloud by your device

CCapital NewsKKenyansFirst

News Coverage

Tuesday 4:04 PMCapital News

Child Deaths Will Rise if Funding for Lifesaving Vaccine Program Falters

Child Deaths Will Rise if Funding for Lifesaving Vaccine Program Falters

The Gates Foundation has committed US$1.6 billion over five years to support Gavi, the Vaccine Alliance, in a bid to prevent rising child mortality rates due to cuts in foreign aid.

Read Story

Key Highlights

The Gates Foundation has committed US$1.6 billion over five years to support Gavi, the Vaccine Alliance, in a bid to prevent rising child mortality rates due to cuts in foreign aid.

  • Bill Gates warns that, for the first time in decades, global child deaths may increase this year.
  • The renewed funding supports Gavi's mission, which has vaccinated over 1.1 billion children and prevented nearly 19 million deaths since its inception.
  • Despite progress, one in five children still lack access to essential vaccines, with outbreaks of preventable diseases threatening gains.
Tuesday 2:27 PMKenyansFirst

New Cherry-Flavoured Malaria Drug for Babies Approved

New Cherry-Flavoured Malaria Drug for Babies Approved

Kenya has approved a new cherry-flavoured malaria drug tailored for infants and young children, a global first that addresses a critical treatment gap.

Read Story

Key Highlights

Kenya has approved a new cherry-flavoured malaria drug tailored for infants and young children, a global first that addresses a critical treatment gap.

  • Coartem Baby is specifically designed for infants under 4.5 kilograms, a category that previously had no approved treatment for malaria.
  • The drug, developed by Novartis, dissolves easily in breast milk and is more palatable for young patients.
  • This development is part of a fast-tracked approval process involving eight African countries, including Burkina Faso, CĂ´te d’Ivoire, and Tanzania, targeting thousands of vulnerable children in malaria-endemic areas.
Advertisement

More from Tuesday, July 8, 2025

Calls for Justice and Accountability in Kenyan Society
Breaking News & Top Stories2 stories

Calls for Justice and Accountability in Kenyan Society

C
K
Capital News, Kenyans
Calls for National Dialogue in Kenya
Kenya Politics & Government2 stories

Calls for National Dialogue in Kenya

S
Standard Politics
Calls for Police Reforms and Press Freedom in Kenya
Entertainment & Culture2 stories

Calls for Police Reforms and Press Freedom in Kenya

G
Ghafla! (Entertainment)
Advertisement

More Stories

Calls for Justice and Accountability in Kenyan Society
Breaking News & Top Stories2 stories

Calls for Justice and Accountability in Kenyan Society

C
K
Capital News, Kenyans
Calls for National Dialogue in Kenya
Kenya Politics & Government2 stories

Calls for National Dialogue in Kenya

S
Standard Politics
Calls for Police Reforms and Press Freedom in Kenya
Entertainment & Culture2 stories

Calls for Police Reforms and Press Freedom in Kenya

G
Ghafla! (Entertainment)
Advertisement